ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 698031 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 698031; 2) Community: the network communities that were significantly associated with the response to NSC 698031; 3) Molecule: the relationships between components within communities and NSC 698031; 4) MDR: the compounds that were significantly associated with the NSC 698031.

NSC Compound Enrichment Correlation
NSC 606498 Camptothecin Derivative 0.00356954838698631 0.097596077
NSC 609699 Topotecan hydrochloride 0.00356954838698631 0.16225638
NSC 624482 Saponaceolide A 0.00356954838698631 0.19037046
NSC 644621 Null 0.00356954838698631 0.23769085
NSC 639505 Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride 0.00454081715455577 0.26293579
NSC 702616 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 4,5,6,7-tetrahydro- 0.00566752757378341 0.18611265
NSC 364830 Camptothecin Derivative 0.00581536684273145 0.15471816
NSC 624166 Null 0.00581536684273145 0.24462226
NSC 636092 Pyridine-3,5-dicarboxamide, 1,4-dihydro-2,6-dimethyl- 4-[4-(dimethylamino)phenyl]-N,N'-diphenyl- 0.00581536684273145 0.34770437
NSC 678401 Glycine, N-[N-[[(4-methoxyphenyl)azo]carbonyl]-L-leucyl]-, dicyclohexylamine salt 0.00581536684273145 0.35307939
Total:27  Current:2    [First] [Prev] [Next] [Last]